CROSS-SECTIONAL CLINICAL STUDY TO EVALUATE THE PTV (PLANNING TARGET VOLUME) MARGIN ERRORS HEAD, NECK, AND BREAST CANCER. Int. Res. J. Pharm. 2018, 9 (12), 130-135.